134 related articles for article (PubMed ID: 23560129)
21. [Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib].
Wollenberg A; Staehler M; Eames T
Hautarzt; 2010 Aug; 61(8):662-7. PubMed ID: 20631979
[TBL] [Abstract][Full Text] [Related]
22. Genital and inguinal cutaneous toxicity in male and female patients treated with sunitinib.
Iacovelli R; Mancini ML; Risi E; Palazzo A; Cortesi E
Int J Dermatol; 2012 Feb; 51(2):221-2. PubMed ID: 22250635
[TBL] [Abstract][Full Text] [Related]
23. Recurrent scrotal hemangiomas during treatment with sunitinib.
Tonini G; Intagliata S; Cagli B; Segreto F; Perrone G; Onetti Muda A; Santini D; Persichetti P
J Clin Oncol; 2010 Dec; 28(35):e737-8. PubMed ID: 20823408
[No Abstract] [Full Text] [Related]
24. Sunitinib adverse event: oral bullous and lichenoid mucositis.
Mignogna MD; Fortuna G; Leuci S; Pollio A; Ruoppo E
Ann Pharmacother; 2009 Mar; 43(3):546-7. PubMed ID: 19240256
[No Abstract] [Full Text] [Related]
25. Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
Kalantari HR
Br J Cancer; 2009 Oct; 101(7):1222-3; author reply 1224. PubMed ID: 19755985
[No Abstract] [Full Text] [Related]
26. Risk of hand-foot skin reaction with the multitargeted kinase inhibitor sunitinib in patients with renal cell and non-renal cell carcinoma: a meta-analysis.
Chu D; Lacouture ME; Weiner E; Wu S
Clin Genitourin Cancer; 2009 Jan; 7(1):11-9. PubMed ID: 19213662
[TBL] [Abstract][Full Text] [Related]
27. Neurosensory retinal detachment due to sunitinib treatment.
Wegner A; Khoramnia R
Eye (Lond); 2011 Nov; 25(11):1517-8. PubMed ID: 21852804
[No Abstract] [Full Text] [Related]
28. [Leg ulcerations and sunitinib].
Guyot-Caquelin P; Granel-Brocard F; Cuny JF; Trechot P; Spaeth D; Marchal A; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2010 Oct; 137(10):626-9. PubMed ID: 20932442
[TBL] [Abstract][Full Text] [Related]
29. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
Story SG; Beschloss JK; Dolan CK; Thomas BC
J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
[No Abstract] [Full Text] [Related]
30. Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy?
Soria JC; Deutsch E
Ann Oncol; 2011 Jun; 22(6):1247-1249. PubMed ID: 21382869
[No Abstract] [Full Text] [Related]
31. Risks associated with sunitinib use and monitoring to improve patient outcomes.
Choi BS
Korean J Intern Med; 2014 Jan; 29(1):23-6. PubMed ID: 24574829
[No Abstract] [Full Text] [Related]
32. Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.
Porta C; Paglino C; Imarisio I; Bonomi L
Clin Exp Med; 2007 Dec; 7(4):127-34. PubMed ID: 18188524
[TBL] [Abstract][Full Text] [Related]
33. Sunitinib-induced thyrotoxicosis.
Piñar D; Boix E; Meana JA; Herrero J
J Endocrinol Invest; 2009 Dec; 32(11):941-2. PubMed ID: 19636224
[No Abstract] [Full Text] [Related]
34. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.
McLellan B; Kerr H
Dermatol Ther; 2011; 24(4):396-400. PubMed ID: 21910797
[TBL] [Abstract][Full Text] [Related]
35. Myelosuppression by sunitinib is flt-3 genotype dependent.
van Erp NP; Mathijssen RH; van der Veldt AA; Haanen JB; Reyners AK; Eechoute K; Boven E; Wessels JA; Guchelaar HJ; Gelderblom H
Br J Cancer; 2010 Aug; 103(5):757-8. PubMed ID: 20683446
[No Abstract] [Full Text] [Related]
36. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.
Kapiteijn E; Brand A; Kroep J; Gelderblom H
Ann Oncol; 2007 Oct; 18(10):1745-7. PubMed ID: 17890216
[No Abstract] [Full Text] [Related]
37. Treatment of hemodialyzed patient with sunitinib.
Reckova M; Kakalejcik M; Beniak J
Ann Oncol; 2009 Feb; 20(2):392-3. PubMed ID: 19136449
[No Abstract] [Full Text] [Related]
38. Lung toxicity in a patient treated with sunitinib.
Boyle HJ; Chatté G; Rivoire M; Fléchon A
Eur Respir J; 2012 Nov; 40(5):1300-3. PubMed ID: 23115316
[No Abstract] [Full Text] [Related]
39. Case of sunitinib-induced Stevens-Johnson syndrome.
Lee JH; Lee JH; Lee JH; Kim SY; Kim GM
J Dermatol; 2013 Sep; 40(9):753-4. PubMed ID: 23855706
[No Abstract] [Full Text] [Related]
40. Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia.
Reyes-Botero G; Gállego Pérez-Larraya J; Sanson M
J Neurooncol; 2012 Apr; 107(2):439-40. PubMed ID: 22076450
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
